Study at a glance
Where is the vitamin D receptor found?
The vitamin D receptor is a protein that helps cells respond to active vitamin D. It is found in many tissues, including the intestine, kidneys, bone and skin. Its amount varies between tissues and between different kinds of cells within the same organ.
Why do studies disagree about where the receptor is present?
Tests differ in what they measure and how reliably they detect small amounts. Some measure receptor protein; others measure the genetic messages used to make it. A weak or missing signal does not always mean the receptor is absent, and a positive signal needs checks to show it really comes from the receptor.
Does finding the vitamin D receptor prove that vitamin D is working?
No. Receptor presence shows one part of the system is there. It does not establish that the receptor is receiving a signal or producing a response in that tissue.
Read the full article below ↓Where the vitamin D receptor is expressed matters, but the question is more difficult than a simple tissue list suggests. VDR can be abundant in one cell population, sparse in another and below the detection threshold of a particular assay in a third. A scientifically useful map therefore has to combine distribution with measurement reliability.
VDR is broadly distributed, but not uniformly
The evidence supports broad VDR expression across classical calcium-regulating tissues and many non-classical targets. Bouillon and colleagues’ synthesis of VDR-null biology places the receptor across intestine, kidney, bone, parathyroid, skin and multiple other systems. The important qualification is that broad distribution does not mean uniform abundance, identical cell localisation or equal biological importance in every tissue.
Pike and colleagues reach the same broader conclusion from modern receptor biology: VDR is expressed in many cell types, yet its abundance and regulatory environment vary substantially. A statement that VDR is ‘everywhere’ loses exactly the information that makes tissue biology interesting.
Cell type can matter more than the organ label
An organ contains multiple cell populations. Detecting VDR somewhere in kidney, skin or pancreas does not establish that every cell in that organ expresses the receptor at the same level. Lee and colleagues used large genomic transgenes to reproduce tissue: and cell-specific VDR expression in mice. Their work showed strong expression in classical target tissues and much lower signals in some other tissues, while immunohistology resolved receptor expression within particular cell populations.
That distinction changes how distribution data should be read. ‘Kidney VDR’ is not a single homogeneous signal. Neither is ‘intestinal VDR’ or ‘skin VDR’. Cell-level localisation is necessary when the biological question concerns a particular epithelial, endocrine or follicular compartment.
Antibody specificity can change the apparent map
Measurement reliability is not an afterthought. Wang, Borchert and DeLuca examined VDR localisation in mouse kidney with a highly specific antibody and VDR-null tissue as a negative control. That knockout-control logic is especially valuable: if staining remains in tissue that genetically lacks VDR, the signal cannot simply be accepted as receptor localisation.
Their study illustrates a general rule for receptor mapping. Immunohistochemistry can be extremely informative, but apparent localisation depends on antibody specificity, tissue preparation, signal threshold and the presence of appropriate negative controls. Older or less specific reagents can produce broader-looking maps than a more selective assay.
Different methods answer different distribution questions
Western blotting, immunohistochemistry, reporter constructs and transcript measurements do not measure the same thing. A Western blot asks whether receptor protein can be detected in a bulk tissue extract. Histology asks where signal appears within tissue architecture. Reporter models can reveal regulatory activity at the VDR locus. RNA abundance measures transcription rather than receptor protein itself.
A negative result with one method can therefore mean several things: true absence, low abundance, restricted expression in a minority cell population, insufficient assay sensitivity or a mismatch between transcript and protein. This is why measurement method belongs inside the biological interpretation rather than being hidden in a methods footnote.
Presence does not equal active signalling
Even reliable detection establishes only that receptor is present. It does not show that ligand is available, that VDR occupies relevant genomic sites, that coregulators are recruited or that a physiological response follows. Receptor presence is one prerequisite within a longer signalling chain.
That distinction is developed further in Why VDR Presence Is Not the Same as Vitamin D Response. For receptor abundance and turnover, see VDR Abundance, Regulation and Receptor Turnover. For causal evidence about what receptor function in a specific tissue actually does, see Tissue-Specific VDR Physiology: Knockout and Rescue Evidence.
How to interpret tissue-distribution claims
The most defensible interpretation is therefore layered. VDR has a broad tissue distribution, but expression is heterogeneous between tissues and between cell types within tissues. The apparent map is also assay-dependent. Strong localisation claims deserve stronger evidence when receptor abundance is low or cell-restricted, ideally including genetic negative controls or convergent methods.
This prevents two opposite errors. One is to treat failure to detect VDR as proof that no biologically relevant receptor exists. The other is to treat any positive staining signal as proof of robust functional signalling. The evidence supports neither shortcut.
The central interpretation
VDR distribution is real but conditional: conditional on tissue, cell type, receptor abundance and the measurement system used to find it. The strongest evidence combines broad physiological mapping with cell-specific localisation and assay controls. That produces a more accurate picture than either an unqualified ‘ubiquitous receptor’ claim or an overly narrow list of classical target organs.
Return to Vitamin D Receptors for the wider receptor framework.
Primary evidence used in this synthesis
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay. PMID 18694980; PMCID PMC2583388; DOI 10.1210/er.2008-0004.
- Identification of the vitamin D receptor in various cells of the mouse kidney · Yongji Wang, Rachael L Borchert, Hector F DeLuca. PMID 22278022; PMCID PMC3343313; DOI 10.1038/ki.2011.463.
- Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A. Bishop, Joseph J. Goellner, Charles A. O’Brien, J. Wesley Pike. PMID 24693968; PMCID PMC4020932; DOI 10.1210/en.2014-1107.
- The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights · J. Wesley Pike, Mark B. Meyer, Seong-Min Lee, Melda Onal, Nancy A. Benkusky. PMID 28240603; PMCID PMC5373853; DOI 10.1172/JCI88887.
Related reading
Why VDR Presence Is Not the Same as Vitamin D Response
Why detecting or measuring VDR does not by itself prove active vitamin D signalling, transcriptional response or tissue-level effect.
Read more →Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats
The present study is aimed to explore whether the aqueous extract of Mori Folium (MF) exhibits bone protective effect by regulating calcium and redox homeostasis in diabetic rats, and to identify the signaling pathways involved in this process.
Original paper ↗Read more →Klotho in the kidney distal convolution regulates urinary Klotho excretion and kidney calcium reabsorption, but not phosphate homeostasis
Klotho acts as a coreceptor for the phosphaturic hormone fibroblast growth factor-23 (FGF-23) and exists in both a membrane-bound and a soluble form (sKlotho) found in blood and urine.
Original paper ↗Read more →VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells
Here, the role of VDR and PDIA3 proteins in membrane response to 1,25(OH)2D3 and calcium signaling was investigated in squamous cell carcinoma A431 cell line with or without the deletion of VDR and PDIA3 genes.
Original paper ↗Read more →VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Full Evidence Review
Examine minute-scale calcium responses and later reporter activity in A431 carcinoma cells, with limits on receptor dependence and clinical interpretation.
Read more →VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Study Summary
Summary of rapid calcium and later reporter responses in A431 cells lacking VDR or PDIA3, separating observed changes from proposed pathway connections.
Read more →Active Vitamin D and Vitamin D Receptor Help Prevent High Glucose Induced Oxidative Stress of Renal Tubular Cells via AKT/UCP2 Signaling Pathway
JC-1 was evaluated by flow cytometry.
Original paper ↗Read more →Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes.
Original paper ↗Read more →MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma
To investigate the expression of miR-125b and vitamin D receptor (VDR) in renal cell carcinoma (RCC) and assess the biological function of miR-125b in RCC.
Original paper ↗Read more →Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease
The objective of this study was to explore whether VDRA administration during the predialysis period is associated with a reduced prevalence of uremic nausea just prior to beginning dialysis.
Original paper ↗Read more →Relationship between vitamin D receptor gene polymorphisms (BsmI, TaqI, ApaI, and FokI) and calcium intake on bone mass in young Japanese women
Therefore, the aim of the present study was to reevaluate the relationship between genetic and dietary factors, as well as its influence on bone mass in young Japanese women, with particular emphasis on vitamin D receptor (VDR) gene polymorphisms and calcium intake.
Original paper ↗Read more →The High Calcium, High Phosphorus Rescue Diet Is Not Suitable to Prevent Secondary Hyperparathyroidism in Vitamin D Receptor Deficient Mice
In a second study, we aimed to study whether RD with additional 1 and 2% calcium (in total 3 and 4% of the diet) is able to prevent secondary hyperparathyroidism in the VDR KO mice.
Original paper ↗Read more →Vitamin D receptor attenuate ischemia-reperfusion kidney injury via inhibiting ATF4
Activating transcription factor 4 (ATF4) is one of the key effectors of endoplasmic reticulum stress (ERS), ATF4/CHOP pathway-mediated ERS plays an important role in the progression of acute kidney disease (AKI).
Original paper ↗Read more →Vitamin D Receptor Gene Polymorphism and Left Ventricular Hypertrophy in Chronic Kidney Disease
FokI and BsmI polymorphisms of vitamin D receptor (VDR) gene are regarded as reliable markers of disturbed vitamin D signaling pathway.
Original paper ↗Read more →Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches
Here, we aimed to assess the correlation between the different alleles of VDR gene polymorphisms and renal cell cancer and breast cancer risks separately through a systematic review of the present literature.
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →FGF23 promotes renal calcium reabsorption through the TRPV5 channel
αKlotho is thought to activate the epithelial calcium channel Transient Receptor Potential Vanilloid-5 (TRPV5) in distal renal tubules through its putative glucuronidase/sialidase activity, thereby preventing renal calcium loss.
Original paper ↗Read more →Phosphate, calcium, and vitamin D signaling, transport, and metabolism in the endometria of cyclic ewes
However, the effects of P4 and estradiol (E2), with respect to the expression of their receptors PGR and ESR1, respectively, in uterine epithelia on mineral signaling during the estrous cycle has not been investigated.
Original paper ↗Read more →The Effect of Vitamin D Supplementation with or without Calcium on Vitamin D Epimer and Metabolites
We therefore aimed to examine the influence of vitamin D3 and calcium supplements on vitamin D epimer and metabolite concentrations in subjects with and those without vitamin D receptor (VDR) gene polymorphisms.
Original paper ↗Read more →Vitamin D Deficiency Aggravates Chronic Kidney Disease Progression after Ischemic Acute Kidney Injury
Rats were randomized into four groups: Control; VDD; ischemia/reperfusion injury (IRI); and VDD+IRI.
Original paper ↗Read more →Original sources
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay.
Publication details
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay. PMID 18694980; PMCID PMC2583388; DOI 10.1210/er.2008-0004.
Identification of the vitamin D receptor in various cells of the mouse kidney
Published in · Yongji Wang, Rachael L Borchert, Hector F DeLuca. PMID 22278022; PMCID PMC3343313; DOI 10.1038/ki (2011).
Publication details
Identification of the vitamin D receptor in various cells of the mouse kidney · Yongji Wang, Rachael L Borchert, Hector F DeLuca. PMID 22278022; PMCID PMC3343313; DOI 10.1038/ki.2011.463.
Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype
Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A.
Publication details
Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A. Bishop, Joseph J. Goellner, Charles A. O’Brien, J. Wesley Pike. PMID 24693968; PMCID PMC4020932; DOI 10.1210/en.2014-1107.
The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights
The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights · J.
Publication details
The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights · J. Wesley Pike, Mark B. Meyer, Seong-Min Lee, Melda Onal, Nancy A. Benkusky. PMID 28240603; PMCID PMC5373853; DOI 10.1172/JCI88887.